Research Frontiers Inc. (NASDAQ:REFR) shares advanced 0.79% in last trading session and ended the day at $5.05. And its has a return on assets of -31.10%. Research Frontiers Inc. (NASDAQ:REFR) quarterly performance is -10.15%.
Research Frontiers Inc. (NASDAQ:REFR) announced that it release its third quarter 2015 financial results on Wednesday, November 4, 2015. In conjunction with the announcement, REFR host a conference call at 4:30 p.m. Eastern Time on Wednesday, November 4, 2015 to discuss its third quarter and year-to-date 2015 financial and operating results as well as recent developments.
Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) ended the last trading day at $181.65. Company weekly volatility is calculated as 10.80% and price to cash ratio as 6.03. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) showed a weekly performance of 8.36%.
Intercept Pharmaceuticals, Inc. (ICPT) (Intercept), announced the results of a 72-week Phase 2 dose ranging trial of obeticholic acid (OCA), Intercept’s lead FXR agonist, in adult patients with nonalcoholic steatohepatitis (NASH) in Japan. The trial was conducted by Intercept’s collaborator, Sumitomo Dainippon Pharma. This trial is the first to evaluate the safety and efficacy of OCA in Japanese NASH patients. The primary efficacy analysis was conducted on an intention to treat (ITT) basis, testing the dose dependent effects of once daily OCA (10mg, 20mg and 40mg) versus placebo on the primary endpoint of a two point improvement in the NAFLD Activity Score (NAS) with no worsening of fibrosis.
On 03 November, Dynex Capital Inc. (NYSE:DX) shares advanced 1.78% and was closed at $6.88. DX EPS growth in last 5 year was -19.70%. Dynex Capital Inc. (NYSE:DX) year to date (YTD) performance is -7.99%.
For the third quarter, Dynex Capital Inc. (NYSE:DX), reported comprehensive loss to common shareholders of $11.9 million, or a loss of 22 cents per common share, and a net loss to common shareholders of $39.3 million, or a loss of 74 cents per common share. The results compare to net income to common shareholders of $28.6 million, or 52 cents per share, in the same quarter a year ago. The Henrico County-based company also reported a third-quarter decline in book value of 34 cents to $8.19 per common share at Sept. 30.
Macy’s, Inc. (NYSE:M) shares moved down -0.31% in last trading session and ended the day at $51.18. M Gross Margin is 39.90% and its has a return on assets of 6.70%. Macy’s, Inc. (NYSE:M) quarterly performance is -25.27%.
Zacks lowered shares of Macy’s (NYSE:M) from a hold rating to a sell rating in a report published on Wednesday.
Civeo Corporation (NYSE:CVEO) caters to the Services space. It has a net profit margin of -32.40% and weekly performance is 20.56%. On the last day of trading company shares ended up at $2.17. Civeo Corporation (NYSE:CVEO) distance from 50-day simple moving average (SMA50) is 18.64%.
Civeo Corporation (NYSE:CVEO) reported financial and operating results for the third quarter ended September 30, 2015.Delivered solid operating cash flows after capital expenditures of $61 million in the third quarter, driven by cost containment, capital discipline and working capital efficiency.Reduced total debt outstanding by 46% to $416 million, down from $775 million at the end of the prior quarter. Completed the Company’s migration to Canada and refinancing in the third quarter, allowing for a more efficient operating and financial structure.
Leave a Reply